New Two-Drug combo tested for Tough-to-Treat uterine cancer
Disease control
Recruiting now
This study is testing whether combining two drugs, avelumab and M1774, can help control a specific type of recurrent endometrial (uterine) cancer that has a mutation in the ARID1A gene. It is for patients whose cancer has come back after prior treatment, including immunotherapy. …
Phase: PHASE2 • Sponsor: Panagiotis Konstantinopoulos, MD, PhD • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC